HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Spinocerebellar Ataxia 17

An autosomal dominant spinocerebellar ataxia that is caused by expanison of TRINUCLEOTIDE REPEATS in the TATA-BOX BINDING PROTEIN (TBP) gene. It is phenotypically similar to HUNTINGTON DISEASE; affected individuals may experience ataxia, pyramidal and extrapyramidal signs, cognitive impairments, psychosis, and seizures. OMIM: 607136
Also Known As:
HDL4 Huntington Disease-Like 4; Huntington Disease-Like 4; SCA17 Spinocerebellar Ataxia 17
Networked: 21 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Neurodegenerative Diseases (Neurodegenerative Disease)
2. Ataxia (Dyssynergia)
3. X-Linked Bulbo-Spinal Atrophy
4. Dyskinesias (Dyskinesia)
5. Spinocerebellar Ataxias (Spinocerebellar Ataxia)

Experts

1. Li, Shihua: 7 articles (01/2018 - 12/2007)
2. Li, Xiao-Jiang: 7 articles (01/2018 - 12/2007)
3. Yang, Su: 5 articles (01/2018 - 07/2011)
4. Cui, Yiting: 2 articles (01/2018 - 01/2017)
5. Guo, Jifeng: 2 articles (01/2018 - 01/2017)
6. Tang, Beisha: 2 articles (01/2018 - 01/2017)
7. Yang, Yang: 2 articles (01/2018 - 01/2017)
8. Ghosh, Tanay: 2 articles (01/2017 - 06/2012)
9. Pillai, Beena: 2 articles (01/2017 - 06/2012)
10. Roshan, Reema: 2 articles (01/2017 - 06/2012)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Spinocerebellar Ataxia 17:
1. TATA-Box Binding Protein (TATA-Binding Protein)IBA
2. tributyl phosphate (TBP)IBA
3. polyglutamineIBA
4. Proteins (Proteins, Gene)FDA Link
5. Androgen Receptors (Androgen Receptor)IBA
6. Protein AggregatesIBA
7. TamoxifenFDA LinkGeneric
8. Prion ProteinsIBA
9. Huntingtin ProteinIBA